Advertisement
Screener

SALIX PHARMACEUTICALS LTD Form D

SALIX PHARMACEUTICALS LTD Form D Notices of Exempt Offering of Securities

Notices filed with the SEC for securities sold without registration under Regulation D or Section 4(a)(5), newest first. Values are as filed.

  • 2014-01-10: Federal exemption Rule 506(b); Types of securities offered Debt; Date of first sale 2013-12-27; Total offering amount $750,000,000.
FiledFederal exemptionTypes of securities offeredDate of first saleTotal offering amountTotal amount soldTotal remaining to be soldInvestors who have already invested
2014-01-10Rule 506(b)Debt2013-12-27$750,000,000$750,000,000$07